John F. Paolini


Cerenis Appoints Non-Executive Director, CMO

Cerenis Therapeutics, the pharma company developing new high-density lipoprortein therapies for cardiovascular and metabolic diseases, Tuesday appointed Richard C. Pasternak to the board of directors and John F. Paolini, M.D., as Chief Medical Officer.

WWJ Newsradio 950–11/22/2011


Get every new post delivered to your Inbox.

Join 3,595 other followers